Viewing Study NCT01605708


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-03-01 @ 9:34 AM
Study NCT ID: NCT01605708
Status: TERMINATED
Last Update Posted: 2013-10-28
First Post: 2011-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module